Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01901653
Brief Title: Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

First Submitted : July 11, 2013
First Submitted that Met QC Criteria : July 15, 2013
First Posted : July 17, 2013 (Estimate)

Results First Submitted : February 6, 2018
Results First Submitted that Met QC Criteria : June 12, 2018
Results First Posted : July 11, 2018

Last Update Submitted that Met QC Criteria : July 10, 2018
Last Update Posted : August 9, 2018